LBH589, a histone deacetylase inhibitor Panobinostat, displayed significant antitumor effects on GBM such as inducing HIF-1α instability, degradation, and decreased VEGF expression [107] (Table 6). The gene discussed is VEGFA; the disease is glioblastoma.